INARI MEDICAL INC. - COMMON STOCK

Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry

12 Mar 2024 16:05:00 By Nasdaq GlobeNewswire

Inari Medical Reports Fourth Quarter 2023 Financial Results

28 Feb 2024 16:05:01 By Nasdaq GlobeNewswire

Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results

14 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance

09 Jan 2024 06:30:00 By Nasdaq GlobeNewswire

Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

20 Dec 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)

27 Nov 2023 16:20:00 By Nasdaq GlobeNewswire

Inari Medical Closes Acquisition of LimFlow

15 Nov 2023 16:05:00 By Nasdaq GlobeNewswire

Inari Medical to Present at Upcoming Investor Conferences

02 Nov 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Reports Third Quarter 2023 Financial Results

01 Nov 2023 16:02:00 By Nasdaq GlobeNewswire

Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow

01 Nov 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Announce Third Quarter 2023 Financial Results

11 Oct 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Present at Upcoming Investor Conferences

24 Aug 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Reports Second Quarter 2023 Financial Results

02 Aug 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Present at the 43rd Annual Canaccord Growth Conference

26 Jul 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Announce Second Quarter 2023 Financial Results

13 Jul 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces Commercial Launch of RevCore™ and Triever16 Curve™, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous Thromboembolism

07 Jun 2023 08:00:01 By Nasdaq GlobeNewswire

Inari Medical Announces the Release of 2022 Ethos and Sustainability Report

25 May 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients

22 May 2023 08:00:01 By Nasdaq GlobeNewswire

Inari Medical Reports First Quarter 2023 Financial Results

03 May 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Present at the Bank of America 2023 Healthcare Conference

02 May 2023 16:01:00 By Nasdaq GlobeNewswire